TB
Trace Biosciences Inc.
SEC filingBiotechnology · Beaverton, OR
Amount raised$8.3Msold at filing
Total offering$16.2M$7.9M still open
Investors in the raise19count reported to the SEC
FiledAug 12, 2026first sale Jul 28, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jonathan SorgerDirector
Connor BarthExecutive Officer, Director
Lei WangExecutive Officer, Director
Summer GibbsExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.